Ameriprise Financial Inc Ionis Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 360,188 shares of IONS stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

360,188

Previous 387,448 7.04%

Holding current value

$14.3 Million

Previous $13.5 Million 19.78%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$30.17 - $34.97 $822,434 - $953,282	-27,260 Reduced 7.04%	360,188 $10.9 Million
Q4 2024 Feb 14, 2025	SELL	$33.73 - $40.36 $352,478 - $421,762	-10,450 Reduced 2.63%	387,448 $13.5 Million
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $15.6 Million - $20.2 Million	389,106 Added 4425.68%	397,898 $15.9 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $250,812 - $328,223	-6,881 Reduced 43.9%	8,792 $419,000
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $418,282 - $532,929	-9,952 Reduced 38.84%	15,673 $679,000
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $772,775 - $919,530	17,810 Added 227.9%	25,625 $1.3 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $55,632 - $68,102	-1,445 Reduced 15.6%	7,815 $354,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $11,912 - $14,862	343 Added 3.85%	9,260 $379,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $148,222 - $181,856	-4,414 Reduced 33.11%	8,917 $318,000
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $941,808 - $1.18 Million	-25,372 Reduced 65.56%	13,331 $503,000
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $998,236 - $1.33 Million	27,319 Added 239.98%	38,703 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $41,159 - $55,814	-1,298 Reduced 10.23%	11,384 $421,000
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $91,283 - $113,157	3,055 Added 31.73%	12,682 $467,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $32,575 - $44,647	-1,272 Reduced 11.67%	9,627 $293,000
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $32,667 - $39,495	974 Added 9.81%	10,899 $366,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $157,260 - $215,129	-4,553 Reduced 31.45%	9,925 $395,000
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $33,200 - $49,812	-781 Reduced 5.12%	14,478 $652,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $215,039 - $286,101	4,747 Added 45.16%	15,259 $865,000
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $25,907 - $34,370	-546 Reduced 4.94%	10,512 $498,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $51,441 - $67,032	1,098 Added 11.02%	11,058 $653,000
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $27,248 - $41,527	655 Added 7.04%	9,960 $472,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $59,665 - $72,319	1,108 Added 13.52%	9,305 $563,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $19,430 - $23,737	329 Added 4.18%	8,197 $490,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $98,474 - $136,618	-1,586 Reduced 16.78%	7,868 $506,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $14,341 - $21,997	271 Added 2.95%	9,454 $767,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $183,151 - $251,437	-4,223 Reduced 31.5%	9,183 $497,000
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $5.66 Million - $7.08 Million	-131,890 Reduced 90.77%	13,406 $692,000
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $2.93 Million - $3.66 Million	72,271 Added 98.97%	145,296 $6.05 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $2.36 Million - $2.94 Million	53,490 Added 273.82%	73,025 $3.22 Million
Q4 2017 Feb 12, 2018	BUY	$50.3 - $64.39 $531,017 - $679,765	10,557 Added 117.59%	19,535 $983,000
Q3 2017 Nov 07, 2017	BUY	$45.56 - $59.57 $409,037 - $534,819	8,978	8,978 $456,000

Others Institutions Holding IONS

# of Institutions

400

Shares Held

145M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Ionis Pharmaceuticals Inc Transaction History